[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Novartis AG Graphic](https://lunarcrush.com/gi/w:26/t:$novnsw.png) Novartis AG

Novartis reports strong Q2 results with double-digit sales growth and raises its profit outlook. The company is also facing discussions about tariffs and strategic moves in the healthcare landscape.

### About Novartis AG
Novartis AG is a multinational pharmaceutical company.  

### Insights [#](/topic/$novnsw/insights)
- Novartis AG mentions is at XXX which is XXX% higher than it's daily average.
- Novartis AG creators is at XXX which is XXX% higher than it's daily average.
- Novartis AG sentiment is up XX% from the previous week.
- Novartis AG creators is up XXXXX% from the previous month.
- Novartis AG engagements is up XXXXX% from the previous week.
- Novartis AG mentions is up XXXXX% from the previous month.
- Novartis AG posts created is up XXXXX% from the previous month.
- Novartis AG Mentions hit a high of XXX for the day
- Novartis AG Mentions hit an all time of XXX for the day

### Price: $ [#](/topic/$novnsw/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$novnsw/time-series/close.tsv)  
The price appears stable due to positive financial reports and high engagement numbers, despite news of a failed late-stage trial for Cosentyx.  

**1-Year High**: $XXXXXX on 2024-09-02  
**1-Year Low**: $XX on 2025-04-09  
  
  
### AltRank: undefined [#](/topic/$novnsw/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$novnsw/time-series/alt_rank.tsv)  
Novartis AG is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: XXX  
**1-Year High**: XXX on 2025-04-01  
**1-Year Low**: XX on 2025-02-26  
  
  
### Galaxy Score: XX [#](/topic/$novnsw/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$novnsw/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1-Year High**: XX on 2025-03-07  
**1-Year Low**: XX on 2024-12-28  
  
  
### Engagements: XXXXXX [#](/topic/$novnsw/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$novnsw/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +77%  
**1 Month**: XXXXXXXXX +26%  
**6 Months**: XXXXXXXXXX -XX%  
**1 Year**: XXXXXXXXXX -XX%  
**1-Year High**: XXXXXXXXX on 2024-12-26  
**1-Year Low**: XXXXX on 2024-07-30  

| Social Network | Reddit | X      | YouTube | TikTok | News |
| -------------- | ------ | -      | ------- | ------ | ---- |
| Engagements    | XX     | XXXXXX | XXXXX   | XXXXX  | XX   |
  

  
  
### Mentions: XXX [#](/topic/$novnsw/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$novnsw/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXX +18%  
**1 Month**: XXXXX +24%  
**6 Months**: XXXXXX +122%  
**1 Year**: XXXXXX +81%  
**1-Year High**: XXX on 2025-07-18  
**1-Year Low**: XX on 2024-09-15  

| Social Network | Reddit | X   | YouTube | TikTok | News |
| -------------- | ------ | -   | ------- | ------ | ---- |
| Mentions       | XX     | XXX | XXX     | XX     | X    |
  

  
  
### Creators: XXX [#](/topic/$novnsw/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$novnsw/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG in the last XX hours which is up XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XXX +10%  
**1 Month**: XXXXX +18%  
**6 Months**: XXXXX +110%  
**1 Year**: XXXXX +119%  
**1-Year High**: XXX on 2025-07-10  
**1-Year Low**: XX on 2024-09-15  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@ThePlayersTV](/creator/twitter/ThePlayersTV)     | X    | XXXXX     | X     | XXXXX       |
| [@novartis](/creator/youtube/novartis)             | X    | XXXXXX    | X     | XXXXX       |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)     | X    | XXX       | X     | XXX         |
| [@practicalshala](/creator/youtube/practicalshala) | X    | XXX       | X     | XXX         |

[View More](/list/creators/$novnsw/100)
  
  
### Sentiment: XX% [#](/topic/$novnsw/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$novnsw/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +20%  
**1 Month**: XX% -X%  
**6 Months**: XX% +18%  
**1 Year**: XX% +10%  
**1-Year High**: XXX% on 2024-08-24  
**1-Year Low**: XX% on 2024-08-13  

**Most Supportive Themes**
- **Positive Impact and Advancements:** (19%) Novartis contributions to healthcare and medical advancements are being positively discussed, showing a high number of posts and engagements.
- **Financial Performance and Dividends:** (13%) Financial performance, dividend recommendations, and growth in markets like India are being positively discussed, which is a major driver of posts.
- **Career Opportunities:** (8%) Job openings, internships, and career opportunities within the company are being actively discussed, showing a good amount of engagement.
  
**Most Critical Themes**
- **Regulatory and Legal Issues:** (1.48%)  Regulatory and legal issues are present in the social posts, indicating potential concerns.
- **Negative Sentiment:** (0.37%)  A very small percentage of negative comments exist across various social media platforms.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| Reddit  | XX       | X%  | XX      | X%  | X        | X% |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXX      | X% |
| YouTube | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
| TikTok  | XXX      | X%  | XXXXX   | X%  | XX       | X% |
| News    | X        | X%  | X       | X%  | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXX      | X% |
  

  
  
### Market Cap: $undefined [#](/topic/$novnsw/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$novnsw/time-series/market_cap.tsv)  
**Current Value**: $undefined  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1-Year High**: $XXXXXXXXXXXXXXX on 2024-09-02  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2024-12-20  

**Top assets mentioned**
In the posts about Novartis AG in the last XX hours

[Novartis AG (NVS)](/topic/novartis)
[Novartis AG (NVS)](/topic/$nvs)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Arcblock (ABT)](/topic/$abt)
[Sanofi (SNY)](/topic/sanofi)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Alphabet Inc Class A (GOOGL)](/topic/$googl)

**Top topics mentioned**
In the posts about Novartis AG in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$nvs](/topic/$nvs), [india](/topic/india), [$pfe](/topic/$pfe), [stocks](/topic/stocks), [youtube](/topic/youtube), [careers](/topic/careers), [babies](/topic/babies), [investment](/topic/investment), [adobe](/topic/adobe), [coins healthcare](/topic/coins-healthcare), [stocks technology](/topic/stocks-technology), [networks](/topic/networks), [cnbc](/topic/cnbc), [tariffs](/topic/tariffs), [netapp](/topic/netapp), [switzerland](/topic/switzerland), [eli](/topic/eli), [$mrk](/topic/$mrk), [drugs](/topic/drugs), [donald trump](/topic/donald-trump), [$novcde](/topic/$novcde), [coins ai](/topic/coins-ai), [$amgn](/topic/$amgn), [$abt](/topic/$abt), [chanel](/topic/chanel), [pep](/topic/pep), [$sdzsw](/topic/$sdzsw), [$baynsg](/topic/$baynsg), [sanofi](/topic/sanofi), [$pidilitindbo](/topic/$pidilitindbo), [$abbv](/topic/$abbv), [eps](/topic/eps), [acquisition](/topic/acquisition), [novo](/topic/novo), [eli lilly](/topic/eli-lilly), [china](/topic/china), [dividend yield](/topic/dividend-yield), [$novn](/topic/$novn), [#fyp](/topic/#fyp), [$googl](/topic/$googl), [stocks communication services](/topic/stocks-communication-services), [applied](/topic/applied), [amc](/topic/amc), [women](/topic/women), [united states](/topic/united-states), [$azn](/topic/$azn), [canada](/topic/canada), [sma](/topic/sma), [$bmy](/topic/$bmy), [quarterly earnings](/topic/quarterly-earnings), [jersey](/topic/jersey), [$issc](/topic/$issc), [stx](/topic/stx), [$bgne](/topic/$bgne), [$6160hk](/topic/$6160hk), [cash flow](/topic/cash-flow), [coins music](/topic/coins-music), [jj](/topic/jj), [mit](/topic/mit), [microsoft](/topic/microsoft), [welcome to](/topic/welcome-to), [$23b](/topic/$23b), [breakthrough](/topic/breakthrough), [stockmarket](/topic/stockmarket), [$stx](/topic/$stx), [#trump](/topic/#trump), [jak](/topic/jak), [russia](/topic/russia), [$4768t](/topic/$4768t), [coins analytics](/topic/coins-analytics), [money](/topic/money), [$1b](/topic/$1b), [longterm](/topic/longterm), [egypt](/topic/egypt), [$xbi](/topic/$xbi), [cfg](/topic/cfg), [$0981hk](/topic/$0981hk), [stocks financial services](/topic/stocks-financial-services), [new york stock exchange](/topic/new-york-stock-exchange), [ipo](/topic/ipo), [manat](/topic/manat), [meta](/topic/meta), [facebook](/topic/facebook), [insurance](/topic/insurance), [approved](/topic/approved), [sap](/topic/sap), [world of](/topic/world-of), [nasdaq](/topic/nasdaq), [hood](/topic/hood), [jpm](/topic/jpm), [nestle](/topic/nestle), [$galdsw](/topic/$galdsw), [$lonnsw](/topic/$lonnsw), [logistics](/topic/logistics), [mahindra](/topic/mahindra), [#ai](/topic/#ai), [wellness](/topic/wellness), [$cop](/topic/$cop), [$crm](/topic/$crm)

### Top News [#](/topic/$novnsw/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Novartis CFO Plans to Retire Psoriasis Drug Disappoints - Bloomberg"  
[@business](/creator/x/business) on [X](/post/news/bloomberg.com-3656971888) 2025-07-17 05:22:51 UTC 9.7M followers, 21.2K engagements



### Top Social Posts [#](/topic/$novnsw/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Trending in Immunology: Crohns Advances Sanofi Deal and More"  
[@LucidQuest-Consulting](/creator/youtube/LucidQuest-Consulting) on [YouTube](/post/youtube-video/oz9M89fQA9c) 2025-07-23 11:24:50 UTC XXX followers, X engagements


"@RonShamgar @ryu_tay same story. when first time FDA rejected their @Illucix . Novartis and Lantheus lobby too strong in US. but TLX is miles ahead from both. so relax @ryu_tay"  
[@AlexaRD445894](/creator/x/AlexaRD445894) on [X](/post/tweet/1947973682003116480) 2025-07-23 10:54:52 UTC XX followers, X engagements


"Guillain-Barre Syndrome market outlook from @delve_insight Market to grow from $XXX M in 2024 to $XXX M by 2034. For More: Key players: @biogen @sanofi @Novartis @pfizer @Roche Grifols and many more #Delveinsight #Biotech #Pharma #Epidemiology"  
[@ethan_taylor008](/creator/x/ethan_taylor008) on [X](/post/tweet/1947957042871947274) 2025-07-23 09:48:44 UTC X followers, XX engagements


"Novartis has received approval for its anti-malaria drug Coartem Baby. It is the first treatment specifically designed for babies the primary victims of the disease. Until now they were treated with tablets for older children adjusted for weight. :"  
[@SwissEmbassyAUS](/creator/x/SwissEmbassyAUS) on [X](/post/tweet/1947945065654952195) 2025-07-23 09:01:09 UTC 1293 followers, XX engagements